<DOC>
	<DOCNO>NCT02335749</DOCNO>
	<brief_summary>Evaluate safety efficacy ZELTIQ CoolSculpting System use small area applicator non-invasive subcutaneous fat reduction distal thigh .</brief_summary>
	<brief_title>Distal Thigh Study</brief_title>
	<detailed_description />
	<mesh_term>Lipid Metabolism Disorders</mesh_term>
	<criteria>Male female subject &gt; 22 year age &lt; 65 year age . Subject clearly visible fat distal thigh , investigator 's opinion , may benefit treatment . Subject weight change exceed 10 pound precede month . Subject body mass index ( BMI ) 30 . BMI define weight pound multiply 703 divide square height inch . Subject agree maintain his/her weight ( i.e. , within 5 % total body weight ) make major change diet exercise routine course study . Subject read sign write informed consent form . Subject surgical procedure ( ) area intend treatment . Subject invasive fat reduction procedure ( e.g. , liposuction , mesotherapy ) area intend treatment . Subject noninvasive fat reduction and/or body contour procedure area intend treatment within past 12 month . Subject need administer , know history subcutaneous injection area intend treatment ( e.g. , heparin , insulin ) within past month . Subject known history cryoglobulinemia , cold urticaria , paroxysmal cold hemoglobinuria . Subject known history Raynaud 's disease , know condition response cold exposure limit blood flow skin . Subject history bleed disorder take medication investigator 's opinion may increase subject 's risk bruising . Subject take take diet pill supplement within past month . Subject dermatological condition , moderate excessive skin laxity , scar location treatment site may interfere treatment evaluation ( stretch mark exclusion ) . Subject active implant device pacemaker , defibrillator , drug delivery system Subject pregnant intending become pregnant study period ( next 5 month ) . Subject lactate lactate past 6 month . Subject unable unwilling comply study requirement . Subject currently enrol clinical study unapproved investigational drug device . Any condition laboratory value would , professional opinion investigator , potentially affect subject 's response integrity data would pose unacceptable risk subject .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>